Alpha-MSH Derivate zur Behandlung von Photodermatosen

European patent · EP2865422 · In force

Register entry

Publication number
EP2865422
Application number
EP14173509
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 31, 2007
Published
Apr 29, 2015
Granted
Oct 18, 2017
Protection ends at the latest
Aug 30, 2027
Next annual fee due
Aug 31, 2027
IPC classes
A61K 38/34 (2006.01)
A61P 17/00 (2006.01)
A61P 17/16 (2006.01)
A61K 8/64 (2006.01)
A61Q 17/04 (2006.01)
A61Q 19/00 (2006.01)
Priority
AU 2006904745 P 31.08.2006
AU 2007900862 P 21.02.2007
Divided from
EP07800234
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 23, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 23.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  6. Oct 27, 2017

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 27.10.2017

  7. Oct 18, 2017

    Granted

    Published in Swissreg on 18.10.2017

Parties

Inventor

Wolgen, Philippe

Melbourne, Victoria 3000, AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.